Insmed Incorporated
Market Cap
$29.43B
P/E Ratio
-21.24
EPS
$-6.42
Dividend Yield
0.00%
52-Week Range
$63.81 — $212.75
Volume
1.34M
Avg Volume
2.28M
Beta
1.10
Get alerted when INSM hits your target price.
Free — enter your email to get started
P/E (TTM)
-21.24
Forward P/E
—
PEG Ratio
7.12
P/S (TTM)
53.72
P/B (TTM)
43.69
P/FCF
-137.26
EV/EBITDA
-89.76x
EV/Sales
—
ROE (TTM)
-1.68%
ROA (TTM)
-0.56%
ROIC
-0.22%
Gross Margin
0.79%
Operating Margin
-1.94%
Net Margin
-2.60%
Debt/Equity
1.04
Current Ratio
3.83
EPS Growth (YoY)
-0.38%
Revenue Growth (YoY)
+0.25%
EPS Growth (3Y)
-0.14%
EPS Growth (5Y)
-0.14%
Sales Growth (3Y)
+0.25%
Sales Growth (5Y)
+0.22%
EPS Est (This Year)
$-2.46
EPS Est (Next Year)
$0.70
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$6.69
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $214.22(57.1% upside)
Institutional %
69.24%
Inst. Net Change
6.70M
Insider Net Shares (90d)
-85101
Outstanding Shares
213.27M
Float
191.33M
Free Float %
89.71%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2000-06-01
Employees
1271
CEO
William H. Lewis
Index Membership
—
Website
https://www.insmed.com
Insmed Incorporated (INSM) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $29.43B, a P/E ratio of -21.24, INSM is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare INSM against other stocks using dozens of fundamental and technical filters.
Insmed Incorporated (INSM) has a trailing twelve-month (TTM) P/E ratio of -21.24. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Insmed Incorporated (INSM) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Insmed Incorporated (INSM) has a market capitalization of $29.43 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Insmed Incorporated (INSM) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $214.22 implies 57.1% upside from the current price.